+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Immunocytological Determination of Gonadotropic and Thyrotropic Cells in Fetal Rat Anterior Pituitary during Normal Development and under Experimental Conditions

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          The appearance and relative distribution of immunoreactive gonadotropic and thyrotropic cells of the anterior pituitary of normal rat fetuses were studied by immunocytology with anti-rat luteinizing hormone serum, anti-porcine luteinizing hormone β serum, anti-bovine thyrotropic hormone serum after saturation with bovine luteinizing hormone. The thyrotropic cells appeared at 17 days of gestation. They were preferentially localized in the dorsal part of the anterior lobe. The gonadotropic cells localized in the ventral part of the same lobe, appeared 1 day later. The number of immunoreactive cells of the two populations increased until the end of gestation. In the pituitaries of 21-day-old rat fetuses encephalectomized at 16 days of gestation, the same number of gonadotropic and thyrotropic cells was observed as in control fetuses at the same age. Gonadotropic cells were also observed in rat adenohypophysial primordia explanted at 14 days of gestation and maintained in organ culture for 7 days. Thyrotropic cells were only stained when the primordia were explanted at 15 days of gestation and cultured for 6 days. No immunoreactive gonadotropic or thyrotropic cells were detected when explantation was performed before 14 days of gestation. These results clarify the problem of the role of hypothalamus on the differentiation of these two cell types.

          Related collections

          Author and article information

          S. Karger AG
          26 March 2008
          : 32
          : 5
          : 285-294
          aLaboratoire d’Histologie et Embryologie, Faculté de Médecine Lyon-Sud, Oullins, France; bLaboratoire de Physiologie animale, Faculté des Sciences, Amiens, France; cINRA, Centre de Recherches de Tours, Monnaie, France
          123174 Neuroendocrinology 1981;32:285–294
          © 1981 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 10
          Original Paper


          Comment on this article